<?xml version="1.0" encoding="iso-8859-1"?><rss version="2.0"><channel><title>Pharma Asia | Business</title><description>Pharma Asia | Business</description><copyright>Copyright 2007 Reed Business Information, a division of Reed Elsevier Inc. All rights reserved.</copyright><image><url></url></image><item><title>Vetter strengthens management team </title><description>From June 1, 2008, Peter Soelkner will head a number of divisions at the Ravensburg-based company, which specializes in the filling of prefilled injection systems. His new tasks will include Global Key ...</description><link>http://www.pharmaasia.com/article-6974-vetterstrengthensmanagementteam-Asia.html</link></item><item><title>Symyx Technologies extends eLearning service</title><description>To help scientists achieve maximum benefit from Symyx software, Symyx Technologies, Inc. has extended its eLearning service (Symyx Learning on Demand) to support Symyx Notebook, the new, enterprise Electronic ...</description><link>http://www.pharmaasia.com/article-6943-symyxtechnologiesextendselearningservice-Asia.html</link></item><item><title>FDA Approves drug delivery system for Watson Pharmaceutical's TRELSTAR DEPOT and TRELSTAR LA</title><description>Watson Pharmaceuticals, Inc. announced that the US Food and Drug Administration has approved MIXJECT, the new delivery system for TRELSTAR (triptorelin pamoate for injectable suspension), a palliative ...</description><link>http://www.pharmaasia.com/article-6938-fdaapprovesdrugdeliverysystemforwatsonpharmaceuticalstrelstardepotandtrelstarla-Asia.html</link></item><item><title>BD announces Q2 results</title><description>Becton, Dickinson and Company has reported record quarterly revenues of $1.747 billion for the second fiscal quarter ended March 31, 2008, representing an increase of 11% over the prior year period. This ...</description><link>http://www.pharmaasia.com/article-6935-bdannouncesq2results-Asia.html</link></item><item><title>Kemin: New VP of regulatory affairs, quality assurance and quality control</title><description>Jed Harms, president of Kemin AgriFoods North America, announces the promotion of Kristi Krafka to Vice President of Regulatory Affairs, Quality Assurance and Quality Control. In this role Kristi provides ...</description><link>http://www.pharmaasia.com/article-6932-keminnewvpofregulatoryaffairsqualityassuranceandqualitycontrol-Asia.html</link></item><item><title>Quintiles ranks first in Pan-European clinical investigator study </title><description>Quintiles Transnational Corp. has announced that an independently conducted study of clinical investigator sites across Europe placed Quintiles first in overall satisfaction. Quintiles was also rated ...</description><link>http://www.pharmaasia.com/article-6927-quintilesranksfirstinpaneuropeanclinicalinvestigatorstudy-Asia.html</link></item><item><title>Oncentra Brachy treatment planning solution for multimodality environment</title><description>Nucletron, a knowledge-based leader in radiation oncology, has announced the introduction of Oncentra Brachy, a comprehensive volume-based treatment planning system to optimize cancer treatment planning ...</description><link>http://www.pharmaasia.com/article-6924-oncentrabrachytreatmentplanningsolutionformultimodalityenvironment-Asia.html</link></item><item><title>New Colibrys VP global operations</title><description>Colibrys has appointed Don Stoops to the role of VP Global operations. He will be responsible worldwide for the strategic management of the Colibrys operations, hence including manufacturing, product ...</description><link>http://www.pharmaasia.com/article-6918-newcolibrysvpglobaloperations-Asia.html</link></item><item><title>GSK And Regulus Therapeutics To Develop microRNA Targeted Therapeutics To Treat Inflammatory Diseases</title><description>GlaxoSmithKline (GSK) and Regulus Therapeutics LLC (Regulus) have announced a worldwide strategic alliance to discover, develop and market novel microRNA-targeted therapeutics to treat inflammatory diseases ...</description><link>http://www.pharmaasia.com/article-6914-gskandregulustherapeuticstodevelopmicrornatargetedtherapeuticstotreatinflammatorydiseases-Asia.html</link></item><item><title>Pfizer, AVANT Enter Into Licensing And Development Agreement </title><description>Pfizer, Inc and AVANT Immunotherapeutics, acting through its wholly-owned subsidiary Celldex Therapeutics, Inc. announced that they have entered into an agreement under which Pfizer will be granted an ...</description><link>http://www.pharmaasia.com/article-6912-pfizeravantenterintolicensinganddevelopmentagreement-Asia.html</link></item></channel></rss>
